Small Cap Value Report (4 Sep) - BLTG, KNOS, BNN, IQE, BVXP, JSG, TAX

Monday, Sep 04 2017 by

Good morning!

It's Labor Day in the US which tends to make the global financial markets a lot quieter than usual. US institutions will be taking the day off.

And while the North Korean hydrogen bomb test might have spooked a few people, the FTSE is only a few points lower as of 8.45. Gold is up another 1% around its 1-year highs.

I don't usually devote any time to macro issues here, but Wall Street being closed and a hydrogen bomb seemed worth mentioning!

I will be starting stock coverage with Blancco Technology (LON:BLTG).



Blancco Technology (LON:BLTG)

  • Share price: 77p (-25%)
  • No. of shares: 64 million
  • Market cap: £49 million

Updates on Revenue and Management

There has been a sea of red flags here for considerable time, both at Blancco and at its predecessor entity Regenersis.

In stock investing, there is such a thing as a smell test, and when a company fails it then you are nearly always better off staying away.

For a review of the various ways that Blancco has stood out as a low-quality offering, have a look through the archives here. It's very genesis as a stock market company was in a failed growth strategy dreamed up by investment bankers. Its accounts have been a mess, cash flow and balance sheet weak, key people have left, etc.

The red flags keep piling up here:

Blancco Technology Group plc announces that, following matters that have recently come to the Board's attention, the Board has decided to reverse £2.9m of revenues represented in two contracts that had previously been booked during the financial year ended 30 June 2017

Revenue growth is still expected to be quite large (15% in constant currency), and cash flow is not impacted. But it confirms over-aggression in the company's revenue recognition policies.

The CEO tacitly takes responsibility by leaving with immediate effect, and the CFO becomes the new Interim CEO.

Remember that the Chairman is leaving next month, and we already had a CFO resignation in March this year.

Something has been rotten about this share from the beginning. In my opinion, it's not yet investible from a corporate governance point of view. Well done to the Stockopedia algorithms for identifying it as a Sucker…

Unlock this article instantly by logging into your account

Don’t have an account? Register for free and we’ll get out your way


All my own views. I am not regulated by the FSA. No advice.

Do you like this Post?
89 thumbs up
0 thumbs down
Share this post with friends

Blancco Technology Group Plc, formerly Regenersis Plc, is a provider of mobile device diagnostics and secure data erasure solutions. The Company's segments include Erasure and Diagnostics. The Erasure segment focuses on development and delivery of solutions, and includes Blancco, which provides erasure software; SafeIT, which is engaged in cloud and networked data erasure business, and Tabernus, which is engaged in providing software erasure products. The Diagnostic segment includes Xcaliber Technologies, a smartphone diagnostics software business. Its secure data erasure solutions include Blancco Management Console, Blancco Cloud, Blancco File, Blancco 5, Blancco Mobile Solutions, Enterprise Erase E800, Enterprise Erase E2400, Enterprise Erase Mobile and Ontrack Eraser Degausser. Its mobile diagnostics solutions include fault diagnostics, repair and program enablement. It serves manufacturers, financial institutions, healthcare providers and government organizations across the world. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

Kainos Group plc is a digital services company. The Company offers information technology products and services to clients in a range of markets, including government, healthcare and financial services. Its segments include Digital Services, Evolve and WorkSmart. The Digital Services segment delivers various system developments of customized online digital solutions for the United Kingdom government and private sector organizations. The Evolve segment is its software platform, which provides over two offerings to the healthcare markets: Evolve electronic medical records (EMR), which is used for digitization, storage and workflow of patient records, and is engaged in the digitization of patient notes in the Acute sector of the national health service (NHS), and Evolve Integrated Care, a cloud-based integrated care solution. The WorkSmart segment provides consulting, project management, integration, support and testing services. It provides software design and development services. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

BNN Technology plc, formerly DJI Holdings PLC, is a content and services company. The Company is engaged in the sale of lottery tickets and related products. The Company is a provider of technology for the promotion and transaction of online bookings, mobile payments and lottery sales in China. The Company, through its Chinese subsidiaries, is engaged in the development, promotion and distribution of authorized lottery products in China. The Company's subsidiaries are licensed and/or contractually authorized to distribute and promote sports and welfare lottery products online, through mobile and through physical retail outlets across China. The Company offers front-end lottery ticket sales through Websites owned and operated by the Company, third-party Websites, mobile applications and physical retail outlets, and back-office lottery ticket fulfilment services to online and offline retailers. The Company operates in China and the United Kingdom. more »

LSE Price
Mkt Cap (£m)
P/E (fwd)
Yield (fwd)

  Is LON:BLTG fundamentally strong or weak? Find out More »

48 Comments on this Article show/hide all

langley59 4th Sep '17 29 of 48

This IQE discussion has brought to mind something about which I have always been confused, namely the definition of trading on inside information. If a select group of analysts obtain information from a company's management which is not generally available to all and is price sensitive and that information is subsequently conveyed to clients and they trade on it is that not market abuse? Similarly if Paul or anyone else has a meeting with management, or if there is a non public meeting such as Mello, would this not potentially be also? I imagine the safeguard is that the management team must not disclose anything which is not publicly available, but then if that is the case what is the benefit of an analyst meeting with them?

| Link | Share | 2 replies
Laughton 4th Sep '17 30 of 48

Email on its way to IQE from me too.

| Link | Share
Sniggolb 4th Sep '17 31 of 48

the prohibition of the likes of Paul is a total disgrace and IQE should tell their advisors to stop being so pompous

| Link | Share
Modform 4th Sep '17 32 of 48

BVXP, the knowledge is not in the people but the process, if the staff leave the company can employ some graduates to the same job as the process has been defined. This will be another ABC,which I have held since Adam was a lad.
A remarkable company.... Buy it, sleep on it imo

| Link | Share
pka 4th Sep '17 33 of 48

In reply to post #214878

Hi PhilH, You wrote:

"Re: IQE ...Speculation ( is suggesting that the new iPhone will be launched on Sept 15th and onsale in the UK by Sept 22nd. Surely that means that any IQE technology that is included has already been manufactured and shipped to component manufacturers that supply Apple. IQE production would have had to have been in place months ago. But IQE with Welsh Assembly Support has only just acquired further manufacturing space. What am I missing?"

IQE has 7 manufacturing facilities around the world. In the Mello presentation in January 2016, the Finance Director said IQE's utilisation of its manufacturing capacity was about 50% at that time. So IQE had plenty of spare capacity to ramp up its manufacture of VCSEL wafers for the launch of the new iPhone. I assume Apple will not want to manufacture too many of the new iPhones before it knows definitely what the demand for them will be from the public. Presumably the further manufacturing space to be leased from the Welsh council will be for the anticipated increase in demand for VCSEL wafers next year, which suggests that IQE's existing 7 manufacturing facilities will be running at near full capacity by then.

| Link | Share | 1 reply
PhilH 4th Sep '17 34 of 48

In reply to post #214978

Hi pka,

Thanks for your response.
Wouldn't increases in things like inventories, purchasing of materials show up in the previous financial reporting?


Professional Services: Sunflower Counselling
| Link | Share
willrimmer1991 4th Sep '17 35 of 48

Hi all,

Does anyone have any idea about the reverse takeover at caml? (central Asia metals)

Am newish to investing and can't get my head around what possible outcomes there may be as it isn't a situation I have come across before.

Thanks in advance

Regards, Will

| Link | Share
crazycoops 4th Sep '17 36 of 48

Re: Central Asia Metals (LON:CAML) rhomboid1 offered a thesis earlier in today's comments which seems plausible. I'm not thrilled about today's news but there is nothing to be done other than wait for details of the proposed transaction and accompanying prospectus. I had one similar earlier this year in Diversified Gas & Oil (LON:DGOC) which worked out well but I am less confident in this instance.

Re: IQE (LON:IQE) They also invested in further capacity in 2016 which some people were questioning at the time. The new facility might not even be for Apple supply chain or even for VCSELs - perhaps it is for their base station work with MACOM? Or it could be for other high demand products.

Re: Bioventix (LON:BVXP) I have just been looking at the Finncap upgrade - 89.3p eps for 2017 and 2018 forecasts are under review,pending new guidance. Happy holder.

Blog: Share Knowledge
| Link | Share
cholertonandrew 4th Sep '17 37 of 48

Hi, I mentioned Nanoco a week or two ago on here. Just in case anyone was looking at it, I'm very cautious at the moment following the recent update. It has promising technology but in my opinion it's probably best to tread very carefully until there's evidence of strong revenues building.


| Link | Share
ls2g08 4th Sep '17 38 of 48

In reply to post #214953

They will have to sign an NDA or similar to receive privileged info if they are wall crossed. I also imagine this may be a factor as Paul wont have a formal compliance dept. and they are worried about the risk of insider info leaking out.

| Link | Share
gsbmba99 4th Sep '17 39 of 48

In reply to post #214953

Theoretically, all the price sensitive information is contained in the results announcement.

Personally, I find watching or listenting to analyst presentations very useful some of the time. It really depends on the management team. The Q&A is usually most useful since the questions are normally asked by people who know the company well. Some management teams are very good at punctuating their presentations with useful factoids that help make the points. I would cite the recent results announcement from NCC (LON:NCC) (available on youtube). That presentation contained a number of factoids that weren't in the results announcement. For example: 1) there was no systematic performance review system under the previous management team 2) the company only billed completed contracts once per month leading to a significant amount of deferred revenue 3) the company, when asked to perform consulting work, frequently didn't ask the customer to issue a purchase order leading to invoices being rejected and subsequently having to get the paperwork sorted 4) the company undertook multiple office moves in the same year with, at times, double office running costs 5) after acuiring Fox IT, a contractor to the Dutch government, the previous management team didn't inform the Dutch government that the cryptologically advanced secure communications system they were delivering to the Dutch government now had a non-Dutch, eventually non-EU parent company leading to a months long suspension of the contract. Are any of these price sensitive? No. However, the mosaic effect of learning these things helped me understand how a company growing organically at 20% could suffer such a huge loss in profitability last year and why management were confident going forward.

| Link | Share
AnonymousUser252054 4th Sep '17 40 of 48

There could so easily be a major improvement with AIM - if current boss Marcus Stuttard was replaced by Tom Winnifrith.

| Link | Share
purpleski 4th Sep '17 41 of 48

In reply to post #214908

Thanks Bruce.

Shows our little I know! But for me information that is deseminated by the managers of a quoted company should not be for the chosen few any more than, for example, the company's accounts are or information that they choose or are obliged to put out on RNS.

Certainly shareholders (if not everybody) should be able to at least hear these analyst meetings even if they can not ask questions. After all they do own the company and the managers are working for them not the analysts! (I can accept that if all attendees were allowed to ask questions the meetings would become impossible).

Surely if information is being placed in the "public" domain i.e. outside of the direct managers, accountants, lawyers and advisers of the company then the information should be available to all, in this day and age, in real time, even if all are not allowed to ask questions. For me it is more about the "all" being able to hear the information at the time.

Anyway I will take John Eustace's advice but I would like the LSE take a stand on this and make (as Ramriddge says) it a listing requirement that analyst calls/meetings are webcast.

| Link | Share
Emperor 4th Sep '17 42 of 48

In reply to post #214933

FREEDA do you think you could get the good people at IQE (LON:IQE) to share their Investor presentation that will be aired at tomorrow's meeting with us mere mortals? They could even put it on their website....

here's hoping

| Link | Share
Michael Mortphew 4th Sep '17 43 of 48

In reply to post #214838

He's very well connected!!

Might be a difficult person to deal with if he tried to throw his weight around. Still Nick Clarke always comes across as a very sound and reliable.

| Link | Share
Bushranger 4th Sep '17 44 of 48

In reply to post #214838

I hope that is not true ref Central Asia Metals (LON:CAML). I can only see that as being bad as I would guess a reason for doing that might be to then sell it off as it is monetised as shares.

| Link | Share
gus 1065 5th Sep '17 45 of 48

IQE (LON:IQE) interims statement link below:-

Results per se are not especially exciting but plenty of Delphic comments in the notes about investment and growth potential with an "H2 mass market consumer device association" to keep the next generation I-phone speculation bandwagon going.


| Link | Share
Samsgrandad 5th Sep '17 46 of 48

There might be a connection between institutional investors not challenging high executive pay and cosy meetings at some companies. Just saying.

| Link | Share
JonBirdy 5th Sep '17 47 of 48

In reply to post #214838

Hi Rhomboid

Saw this on ADVFN. In tune with your Central Asia Metals (LON:CAML) speculation. I hold btw.

Could be Kenges Rakishev is lining up a London quote for SAT & Company?

Since November 2006 Kenges Rakishev is the large shareholder and chairman of the board of SAT & Company (KASE: SATC), a diversified industrial holding combining more than 30 companies across different industrial sectors, such as mining, metallurgy, construction, mechanical engineering, oil trading, minerals exploration and recycling.

From 2008 Sat & Company rapidly increased its international presence through acquisition of the new assets in China and Turkey (ferroalloy plants and mining companies exploring ferroalloys, chrome, nickel, zinc and coal). According to Bloomberg, by the beginning of 2013 market capitalization of Sat & Company made up $500 mln. By December 2015 Rakishev gained control over 75,61% of the company's shares.

In June 27, 2013 Central Asia Metals (LON:CAML) became the sole owner of Kounrad copper project in Kazakhstan by exchanging 20% of Central Asia Metals (LON:CAML) shares into 40% of Kounrad stake owned by Kenges. Thus, Kenges was appointed as non-executive director of Central Asia Metals plc.

On March 13, 2014 Kenges Rakishev joined the board of directors of JSC "National Company "Kazakhstan Engineering" - large holding combining 27 enterprises of the defensive industry and munitions factories of the Ministry of Defence of the Republic of Kazakhstan. He left the board one year later, upon the appointment of Imangali Tasmagambetov as the new Minister of Defence.

| Link | Share
mrosbiston 5th Sep '17 48 of 48

probably already been mentioned - but IQE has formed a fairly clear VCP pattern. As a stage two stock it seems to be on its third base, the pick up in volume shows the increase in institutional attention. The reaction today seems very positive, could be another 1-2 bases left in the stage two move - definitely likely to pick-up in volatility

| Link | Share

Please subscribe to submit a comment

 Are LON:BLTG's fundamentals sound as an investment? Find out More »

About Graham Neary

Graham Neary

Full-time investor and independent analyst. Prior to this, I spent seven years in the financial markets as an analyst and institutional fund manager. I'm CFA-qualified, also holding the Investment Management Certificate and the STA Diploma in Technical Analysis.Away from finance, my main interests are recreational poker and everything to do with China, especially Mandarin Chinese. more »


Stock Picking Tutorial Centre

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis